An initial methemoglobin level was elevated, at 7.6%, during treatment (normal range: 0–1.5) on dapsone and MB, but the patient denied any significant symptoms of methemoglobinemia as she denied any blue hands, blue lips, headaches, significant fatigue, or shortness of breath. This evidence concerns the gene HBG2 and methemoglobinemia.